NewGenIvf Group Limited
$2.19
▼
-1.39%
2026-04-21 08:25:00
www.nivf.global
NCM: NIVF
Explore NewGenIvf Group Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.32 M
Current Price
$2.19
52W High / Low
$7,356 / $1.52
Stock P/E
0.08
Book Value
$110.5
Dividend Yield
—
ROCE
-135.35%
ROE
79.4%
Face Value
—
EPS
$36.48
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
87
Beta
0.09
Debt / Equity
18.74
Current Ratio
3.12
Quick Ratio
2.98
Forward P/E
0.22
Price / Sales
0.25
Enterprise Value
$4.43 M
EV / EBITDA
-0.42
EV / Revenue
0.94
Rating
Strong Buy
Target Price
$900
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 2. | agilon health, inc. | $28.3 | — | $499.01 M | — | -219.27% | -1.36% | $141 / $7.48 | $7.64 |
| 3. | DocGo Inc. | $0.68 | — | $64.06 M | — | -59.59% | -89.05% | $2.45 / $0.49 | $1.46 |
| 4. | InnovAge Holding Corp. | $7.95 | 172.72 | $1.12 B | — | -4.46% | 1.18% | $10.69 / $2.6 | $1.89 |
| 5. | The Ensign Group, Inc. | $190 | 32.56 | $11.11 B | 0.13% | 9.31% | 16.89% | $218 / $118.73 | $38.71 |
| 6. | PACS Group, Inc. | $36 | 28.88 | $5.53 B | — | 6.76% | 22.96% | $43.08 / $7.5 | $6.04 |
| 7. | Basel Medical Group Ltd | $0.62 | — | $10.73 M | — | -25.54% | -1.64% | $9.4 / $0.49 | $0.23 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 1.42 M | 1.28 M | 1.27 M | 1.47 M |
| Operating Profit | -4.97 M | -2.51 M | -1.09 M | 0.22 M |
| Net Profit | -7.67 M | 16.82 M | -0.11 M | -0.02 M |
| EPS in Rs | -13.49 | 29.59 | -0.19 | -0.03 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.73 M | 5.43 M | 5.14 M | 5.94 M |
| Operating Profit | -10.73 M | -1.16 M | 0.04 M | 0.4 M |
| Net Profit | 9.88 M | -0.52 M | 0.13 M | 0.46 M |
| EPS in Rs | 17.38 | -0.92 | 0.23 | 0.81 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 32.72 M | 3.58 M | 4.49 M | 2.9 M |
| Total Liabilities | 6.74 M | 5.06 M | 1.24 M | 2.8 M |
| Equity | 26.63 M | -1.05 M | 3.74 M | 0.56 M |
| Current Assets | 7.38 M | 3.17 M | 2.46 M | 2.4 M |
| Current Liabilities | 2.37 M | 2.72 M | 1.12 M | 2.56 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.93 M | -8.26 M | -1.77 M | 1.71 M |
| Investing CF | -7.56 M | -0.05 M | -0.07 M | -0.09 M |
| Financing CF | 18.99 M | 8.68 M | 1.88 M | -1.63 M |
| Free CF | -16.68 M | -8.32 M | -1.84 M | 1.62 M |
| Capex | -5.75 M | -0.05 M | -0.07 M | -0.09 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -13.01% | 5.79% | -13.59% | — |
| Earnings Growth % | 1983.07% | -502.97% | -71.61% | — |
| Profit Margin % | 209.02% | -9.66% | 2.53% | 7.72% |
| Operating Margin % | -226.95% | -21.36% | 0.82% | 6.71% |
| Gross Margin % | 20.22% | 33.62% | 32.74% | 25.87% |
| EBITDA Margin % | 229.45% | 0.44% | 7.48% | 12.21% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-03-16 | 1:0.25 |
| 2026-01-26 | 1:0.333333 |
| 2025-12-01 | 1:0.2 |
| 2025-08-04 | 1:0.2 |
| 2025-05-05 | 1:0.1 |